News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Multifaceted Approach to Alzheimer’s Treatment in a Pill, T3D Therapeutics Reveals


9/13/2013 7:17:54 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

There is no known cure for Alzheimer’s, and every promising treatment candidate has failed to produce results in large scale clinical trials. Startup company T3D Therapeutics believes that this is because there may be several Alzheimer’s pathologies which have not been adequately addressed by recent attempts to develop an effective medicine. The current general consensus is that insulin resistance in brain cells, which causes symptoms such as glucose imbalance, insulin imbalance and beta amyloid plaque buildup, could be the potential trigger for Alzheimer’s.

Hey, check out all the research scientist jobs. Post your resume today!

Read at medgadget

comments powered by Disqus
medgadget
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES